By targeting the precise mechanism of ferritinophagy, we envisage that strategies focused on increasing JWA expression, exemplified by JAC4 treatment, could offer a novel avenue for neuroprotection in PD. This evidence concerns the gene ARL6IP5 and Parkinson disease.